文献速递耳科与耳神经头颈外科

PD-1抑制剂对顺铂诱导毒性的小鼠模型影响轻微

PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model.
PubMed 文献 · Otolaryngol Head Neck Surg · 2018-04-03

本研究在顺铂诱导听力损失的小鼠模型中,评估抗PD-1免疫治疗对听性脑干反应(ABR)、畸变产物耳声发射(DPOAEs)、血清肌酐及毛细胞和肾脏组织学的影响。结果显示PD-1抑制仅导致14.4和16 kHz处DPOAE轻度恶化及血清肌酐轻度升高,ABR、毛细胞和肾脏组织学无变化,提示PD-1抑制联合顺铂的毒性与单用顺铂相似。

要点

  • PD-1抑制对顺铂诱导的ABR和毛细胞组织学无影响。
  • PD-1抑制仅轻微加重高频DPOAE和血清肌酐。
  • 联合治疗的毒性总体与单用顺铂相似。

核心结论

  • PD-1抑制联合顺铂的毒性与单用顺铂相似。

研究设计与样本

  • 小鼠模型研究,采用顺铂诱导听力损失模型。

主要发现

  • DPOAE在14.4和16 kHz处轻度恶化。
  • 血清肌酐轻度升高。
  • ABR、毛细胞和肾脏组织学无变化。

临床怎么用

  • 提示PD-1抑制剂联合顺铂时无需过度担忧额外耳肾毒性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Immune checkpoint inhibition used in combination with standard cisplatin-based chemotherapy regimens is currently under evaluation in clinical trials for head and neck squamous cell carcinoma (HNSCC). The impact of anti-PD-1 therapy on cisplatin-induced ototoxicity and nephrotoxicity has not been established. Here we use a murine model of cisplatin-induced hearing loss to investigate the impact of anti-PD-1 immunotherapy on auditory brainstem responses (ABRs), distortion product otoacoustic emissions (DPOAEs), serum creatinine, and hair cell and renal histology. We demonstrate only mild worsening of DPOAEs at 14.4 and 16 kHz as well as a mild increase in serum creatinine. Renal and hair cell histology as well as ABR measures were unchanged by PD-1 inhibition. Thus, our data suggest that the use of PD-1 inhibition in conjunction with cisplatin results in toxicities that are similar to those of cisplatin alone.

来源:Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Spielbauer K, Cunningham L, Schmitt N, et al. PD-1 Inhibition Minimally Affects Cisplatin-Induced Toxicities in a Murine Model. Otolaryngol Head Neck Surg. 2018. PMID: 29609517. doi:10.1177/0194599818767621

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。